Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.10 |
|---|---|
| High | 4.10 |
| Low | 4.10 |
| Bid | 4.10 |
| Offer | 4.22 |
| Previous close | 4.06 |
| Average volume | 3.08k |
|---|---|
| Shares outstanding | 353.82m |
| Free float | 305.38m |
| P/E (TTM) | -- |
| Market cap | 1.74bn USD |
| EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:00 GMT.
More ▼
Press releases
- New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
- Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
- Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
